JPMorgan Chase & Co’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,781
| Closed | -$233K | – | 6332 |
|
|
2022
Q4 | $233K | Buy |
10,781
+1,283
| +14% | +$27.7K | ﹤0.01% | 4137 |
|
|
2022
Q3 | $183K | Buy |
9,498
+190
| +2% | +$3.66K | ﹤0.01% | 4212 |
|
|
2022
Q2 | $186K | Buy |
9,308
+1,298
| +16% | +$25.9K | ﹤0.01% | 4352 |
|
|
2022
Q1 | $239K | Buy |
8,010
+1,341
| +20% | +$40K | ﹤0.01% | 4360 |
|
|
2021
Q4 | $156K | Buy |
6,669
+302
| +5% | +$7.06K | ﹤0.01% | 4655 |
|
|
2021
Q3 | $199K | Sell |
6,367
-202
| -3% | -$6.31K | ﹤0.01% | 4416 |
|
|
2021
Q2 | $232K | Buy |
6,569
+154
| +2% | +$5.44K | ﹤0.01% | 4420 |
|
|
2021
Q1 | $226K | Sell |
6,415
-1,118
| -15% | -$39.4K | ﹤0.01% | 4411 |
|
|
2020
Q4 | $282K | Buy |
7,533
+2,575
| +52% | +$96.4K | ﹤0.01% | 4040 |
|
|
2020
Q3 | $162K | Buy |
4,958
+461
| +10% | +$15.1K | ﹤0.01% | 3832 |
|
|
2020
Q2 | $119K | Sell |
4,497
-9,927
| -69% | -$263K | ﹤0.01% | 3883 |
|
|
2020
Q1 | $235K | Buy |
14,424
+5,333
| +59% | +$86.9K | ﹤0.01% | 3656 |
|
|
2019
Q4 | $231K | Buy |
9,091
+5,524
| +155% | +$140K | ﹤0.01% | 3753 |
|
|
2019
Q3 | $71K | Buy |
3,567
+731
| +26% | +$14.6K | ﹤0.01% | 4113 |
|
|
2019
Q2 | $90K | Buy |
2,836
+614
| +28% | +$19.5K | ﹤0.01% | 4057 |
|
|
2019
Q1 | $72K | Sell |
2,222
-104
| -4% | -$3.37K | ﹤0.01% | 4109 |
|
|
2018
Q4 | $57K | Buy |
2,326
+216
| +10% | +$5.29K | ﹤0.01% | 4227 |
|
|
2018
Q3 | $70K | Sell |
2,110
-1,001
| -32% | -$33.2K | ﹤0.01% | 4238 |
|
|
2018
Q2 | $111K | Buy |
+3,111
| New | +$111K | ﹤0.01% | 4049 |
|
|
2017
Q4 | – | Sell |
-200
| Closed | -$4K | – | 4763 |
|
|
2017
Q3 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 4155 |
|